Benjamin Withey

Benjamin Withey has extensive experience in business development and strategic account management within the pharmaceutical and diagnostics sectors. Notably, Withey served as Senior Director of Strategic Accounts for Pharma Services at NeoGenomics Laboratories from February 2018 to November 2022, before taking on roles at Discovery Life Sciences and Seagen, where Withey held the position of Senior Director of Business Development and Associate Director, Commercial Diagnostics, respectively. Currently, Withey is the Director of Commercial Diagnostics - CDx Lead at Pfizer, a position assumed in January 2024. Withey's earlier career includes a role as Business Development Manager for Histology Services at Flagship Biosciences and senior positions at Definiens. Withey holds a Bachelor’s Degree from Northern Arizona University, earned between 2003 and 2007.